NeoGenomics, Inc.(NASDAQ: NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced the launch of PTEN IHC CDx, the first immunohistochemistry (IHC) ...
(NASDAQ: NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced that it will report its second quarter 2026 financial results after the close of U.S.
As high prices and sluggish consumer spending drag on, support for small-business owners is shifting rapidly from reactive ...
Exponent gets a buy rating: its expert consulting thrives in high-stakes, regulated technical failures. Click for more on ...
The visibility gap every marketing team facesBrands are now investing significant resources in social media, creators, influencers, and digital partnerships, regardless of the industry in which they ...
The anxiety of the trends to sustain above 24000 was laid to rest as the market realigned its forces to stage a strong rise over the past few days. The anxiety of the trends to sustain above 24000 was ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...